# Sabre Corp: financial statements, quarterly

SABR · Nasdaq · CIK 1597033 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sabr.md) · [Financials](/companies/sabr/financials.md) · [Filings](/companies/sabr/filings.md) · [Insiders](/companies/sabr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sabr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [740](/filings/0001597033-24-000125.md) | [421 d](/filings/0001628280-26-008800.md) | [783](/filings/0001597033-25-000061.md) | [695](/filings/0001597033-25-000090.md) | [691](/filings/0001628280-25-049383.md) | [645 d](/filings/0001628280-26-008800.md) | [702](/filings/0001628280-26-031723.md) | [687](/filings/0001628280-26-053876.md) | [715](/filings/0001628280-25-049383.md) | [667 d](/filings/0001628280-26-008800.md) | [760](/filings/0001628280-26-031723.md) | [712](/filings/0001628280-26-053876.md) |
| Cost of revenue | $m | [294](/filings/0001597033-24-000125.md) | [159 d](/filings/0001628280-26-008800.md) | [321](/filings/0001597033-25-000061.md) | [293](/filings/0001597033-25-000090.md) | [295](/filings/0001628280-25-049383.md) | [266 d](/filings/0001628280-26-008800.md) | [305](/filings/0001628280-26-031723.md) | [296](/filings/0001628280-26-053876.md) | [313](/filings/0001628280-25-049383.md) | [292 d](/filings/0001628280-26-008800.md) | [335](/filings/0001628280-26-031723.md) | [310](/filings/0001628280-26-053876.md) |
| Selling, general and administrative | $m | [151](/filings/0001597033-24-000125.md) | [88.7 d](/filings/0001628280-26-008800.md) | [141](/filings/0001597033-25-000061.md) | [154](/filings/0001597033-25-000090.md) | [149](/filings/0001628280-25-049383.md) | [143 d](/filings/0001628280-26-008800.md) | [130](/filings/0001628280-26-031723.md) | [129](/filings/0001628280-26-053876.md) | [140](/filings/0001628280-25-049383.md) | [158 d](/filings/0001628280-26-008800.md) | [134](/filings/0001628280-26-031723.md) | [138](/filings/0001628280-26-053876.md) |
| Operating income | $m | [52.2](/filings/0001597033-24-000125.md) | [22.4 d](/filings/0001628280-26-008800.md) | [98.1](/filings/0001597033-25-000061.md) | [48.7](/filings/0001597033-25-000090.md) | [57.8](/filings/0001628280-25-049383.md) | [46.1 d](/filings/0001628280-26-008800.md) | [91.4](/filings/0001628280-26-031723.md) | [89.1](/filings/0001628280-26-053876.md) | [93.6](/filings/0001628280-25-049383.md) | [21.3 d](/filings/0001628280-26-008800.md) | [116](/filings/0001628280-26-031723.md) | [92.8](/filings/0001628280-26-053876.md) |
| Interest expense | $m | [119](/filings/0001597033-23-000108.md) | [123 d](/filings/0001597033-24-000020.md) | [125](/filings/0001597033-24-000073.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [8.5](/filings/0001597033-24-000125.md) | [17.1 d](/filings/0001628280-26-008800.md) | [2.9](/filings/0001597033-25-000061.md) | [5.9](/filings/0001597033-25-000090.md) | [7.2](/filings/0001628280-25-049383.md) | [(12.5) d](/filings/0001628280-26-008800.md) | [(11.6)](/filings/0001628280-26-031723.md) | [91.3](/filings/0001628280-26-053876.md) | [(58.5)](/filings/0001628280-25-049383.md) | [(4.8) d](/filings/0001628280-26-008800.md) | [(11.4)](/filings/0001628280-26-031723.md) | [11.7](/filings/0001628280-26-053876.md) |
| Net income | $m | [(208)](/filings/0001597033-24-000125.md) | [(96.5) d](/filings/0001628280-26-008800.md) | [(71.5)](/filings/0001597033-24-000073.md) | [(69.8)](/filings/0001597033-24-000106.md) | [(62.8)](/filings/0001597033-24-000125.md) | [(74.7) d](/filings/0001628280-26-008800.md) | [35.5](/filings/0001628280-26-031723.md) | [(257)](/filings/0001628280-26-053876.md) | [848](/filings/0001628280-25-049383.md) | [(103) d](/filings/0001628280-26-008800.md) | [8.0](/filings/0001628280-26-031723.md) | [(36.2)](/filings/0001628280-26-053876.md) |
| Diluted EPS | $ per share | [(0.61)](/filings/0001597033-24-000125.md) | not reported | [(0.19)](/filings/0001597033-25-000061.md) | [(0.18)](/filings/0001597033-25-000090.md) | [(0.16)](/filings/0001628280-25-049383.md) | not reported | [0.09](/filings/0001628280-26-031723.md) | [(0.65)](/filings/0001628280-26-053876.md) | [1.98](/filings/0001628280-25-049383.md) | not reported | [0.02](/filings/0001628280-26-031723.md) | [(0.09)](/filings/0001628280-26-053876.md) |
| Basic EPS | $ per share | [(0.61)](/filings/0001597033-24-000125.md) | not reported | [(0.19)](/filings/0001597033-25-000061.md) | [(0.18)](/filings/0001597033-25-000090.md) | [(0.16)](/filings/0001628280-25-049383.md) | not reported | [0.09](/filings/0001628280-26-031723.md) | [(0.65)](/filings/0001628280-26-053876.md) | [2.15](/filings/0001628280-25-049383.md) | not reported | [0.02](/filings/0001628280-26-031723.md) | [(0.09)](/filings/0001628280-26-053876.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [602](/filings/0001597033-23-000108.md) | [648](/filings/0001597033-25-000027.md) | [629](/filings/0001597033-24-000073.md) | [613](/filings/0001597033-24-000106.md) | [669](/filings/0001597033-24-000125.md) | [724](/filings/0001628280-26-008800.md) | [651](/filings/0001597033-25-000061.md) | [426](/filings/0001597033-25-000090.md) | [662](/filings/0001628280-25-049383.md) | [792](/filings/0001628280-26-053876.md) | [644](/filings/0001628280-26-031723.md) | [676](/filings/0001628280-26-053876.md) |
| Current assets | $m | [1,196](/filings/0001597033-23-000108.md) | [1,159](/filings/0001597033-25-000027.md) | [1,227](/filings/0001597033-24-000073.md) | [1,166](/filings/0001597033-24-000106.md) | [1,196](/filings/0001597033-24-000125.md) | [1,163](/filings/0001628280-26-008800.md) | [1,224](/filings/0001597033-25-000061.md) | [953](/filings/0001597033-25-000090.md) | [1,157](/filings/0001628280-25-049383.md) | [1,296](/filings/0001628280-26-053876.md) | [1,134](/filings/0001628280-26-031723.md) | [1,169](/filings/0001628280-26-053876.md) |
| Total assets | $m | [4,742](/filings/0001597033-23-000108.md) | [4,672](/filings/0001597033-25-000027.md) | [4,738](/filings/0001597033-24-000073.md) | [4,666](/filings/0001597033-24-000106.md) | [4,693](/filings/0001597033-24-000125.md) | [4,635](/filings/0001628280-26-008800.md) | [4,678](/filings/0001597033-25-000061.md) | [4,419](/filings/0001597033-25-000090.md) | [4,373](/filings/0001628280-25-049383.md) | [4,502](/filings/0001628280-26-053876.md) | [4,333](/filings/0001628280-26-031723.md) | [4,372](/filings/0001628280-26-053876.md) |
| Current liabilities | $m | [908](/filings/0001597033-23-000108.md) | [915](/filings/0001597033-25-000027.md) | [893](/filings/0001597033-24-000073.md) | [1,086](/filings/0001597033-24-000106.md) | [1,173](/filings/0001597033-24-000125.md) | [1,142](/filings/0001628280-26-008800.md) | [1,117](/filings/0001597033-25-000061.md) | [947](/filings/0001597033-25-000090.md) | [1,018](/filings/0001628280-25-049383.md) | [1,214](/filings/0001628280-26-053876.md) | [1,225](/filings/0001628280-26-031723.md) | [1,140](/filings/0001628280-26-053876.md) |
| Long-term debt | $m | [4,817](/filings/0001597033-23-000108.md) | [4,829](/filings/0001597033-25-000027.md) | [4,985](/filings/0001597033-24-000073.md) | [4,789](/filings/0001597033-24-000106.md) | [4,790](/filings/0001597033-24-000125.md) | [4,835](/filings/0001628280-26-008800.md) | [4,885](/filings/0001597033-25-000061.md) | [4,997](/filings/0001597033-25-000090.md) | [4,063](/filings/0001628280-25-049383.md) | [4,103](/filings/0001628280-26-053876.md) | [3,912](/filings/0001628280-26-031723.md) | [4,064](/filings/0001628280-26-053876.md) |
| Current portion of debt | $m | [4.0](/filings/0001597033-23-000108.md) | [4.0](/filings/0001597033-25-000027.md) | [3.2](/filings/0001597033-24-000073.md) | [219](/filings/0001597033-24-000106.md) | [246](/filings/0001597033-24-000125.md) | [231](/filings/0001628280-26-008800.md) | [233](/filings/0001597033-25-000061.md) | [42.5](/filings/0001597033-25-000090.md) | [155](/filings/0001628280-25-049383.md) | [248](/filings/0001628280-26-053876.md) | [358](/filings/0001628280-26-031723.md) | [254](/filings/0001628280-26-053876.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [(1,283)](/filings/0001597033-24-000125.md) | [(1,376)](/filings/0001628280-26-008800.md) | [(1,430)](/filings/0001628280-25-049383.md) | [(1,491)](/filings/0001628280-25-049383.md) | [(1,543)](/filings/0001628280-25-049383.md) | [(1,605)](/filings/0001628280-26-053876.md) | [(1,559)](/filings/0001628280-26-053876.md) | [(1,804)](/filings/0001628280-26-053876.md) | [(951)](/filings/0001628280-25-049383.md) | [(1,036)](/filings/0001628280-26-053876.md) | [(1,026)](/filings/0001628280-26-053876.md) | [(1,055)](/filings/0001628280-26-053876.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [59.4 d](/filings/0001597033-24-000125.md) | [107 d](/filings/0001628280-26-008800.md) | [(68.1)](/filings/0001597033-25-000061.md) | [38.2 d](/filings/0001597033-25-000090.md) | [24.4 d](/filings/0001628280-25-049383.md) | [75.7 d](/filings/0001628280-26-008800.md) | [(80.6)](/filings/0001597033-25-000061.md) | [(201) d](/filings/0001628280-26-053876.md) | [33.7 d](/filings/0001628280-25-049383.md) | [139 d](/filings/0001628280-26-008800.md) | [(134)](/filings/0001628280-26-031723.md) | [36.1 d](/filings/0001628280-26-053876.md) |
| Capital expenditure | $m | [20.4](/filings/0001597033-23-000108.md) | [12.3 d](/filings/0001628280-26-008800.md) | [27.7](/filings/0001597033-25-000061.md) | [17.9 d](/filings/0001597033-25-000090.md) | [19.3 d](/filings/0001628280-25-049383.md) | [14.7 d](/filings/0001628280-26-008800.md) | [16.9](/filings/0001628280-26-031723.md) | [22.3 d](/filings/0001628280-26-053876.md) | [20.3 d](/filings/0001628280-25-049383.md) | [23.5 d](/filings/0001628280-26-008800.md) | [21.2](/filings/0001628280-26-031723.md) | [26.4 d](/filings/0001628280-26-053876.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations, us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [328](/filings/0001597033-23-000108.md) | [329](/filings/0001597033-24-000073.md) | [332](/filings/0001597033-24-000106.md) | [345](/filings/0001597033-24-000125.md) | [380](/filings/0001597033-25-000061.md) | [384](/filings/0001597033-25-000090.md) | [386](/filings/0001628280-25-049383.md) | [386](/filings/0001628280-26-031723.md) | [391](/filings/0001628280-26-053876.md) | [429](/filings/0001628280-25-049383.md) | [398](/filings/0001628280-26-031723.md) | [399](/filings/0001628280-26-053876.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 403,583,214 at 2026-07-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-053876.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.